img

Global Gene Therapies for Tumor Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gene Therapies for Tumor Treatment Market Research Report 2024

Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
According to Mr Accuracy reports new survey, global Gene Therapies for Tumor Treatment market is projected to reach US$ 20270 million in 2029, increasing from US$ 4915 million in 2022, with the CAGR of 20.1% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gene Therapies for Tumor Treatment market research.
The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gene Therapies for Tumor Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis
Gilead Sciences
Amgen
Shanghai Sunway
Sibiono
Segment by Type
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer

Segment by Application


Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Gene Therapies for Tumor Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gene Induced Immunotherapy
1.2.3 Oncolytic Virotherapy
1.2.4 Gene Transfer
1.3 Market by Application
1.3.1 Global Gene Therapies for Tumor Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapies for Tumor Treatment Market Perspective (2018-2029)
2.2 Gene Therapies for Tumor Treatment Growth Trends by Region
2.2.1 Global Gene Therapies for Tumor Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Therapies for Tumor Treatment Historic Market Size by Region (2018-2024)
2.2.3 Gene Therapies for Tumor Treatment Forecasted Market Size by Region (2024-2029)
2.3 Gene Therapies for Tumor Treatment Market Dynamics
2.3.1 Gene Therapies for Tumor Treatment Industry Trends
2.3.2 Gene Therapies for Tumor Treatment Market Drivers
2.3.3 Gene Therapies for Tumor Treatment Market Challenges
2.3.4 Gene Therapies for Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapies for Tumor Treatment Players by Revenue
3.1.1 Global Top Gene Therapies for Tumor Treatment Players by Revenue (2018-2024)
3.1.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapies for Tumor Treatment Revenue
3.4 Global Gene Therapies for Tumor Treatment Market Concentration Ratio
3.4.1 Global Gene Therapies for Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Tumor Treatment Revenue in 2022
3.5 Gene Therapies for Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Gene Therapies for Tumor Treatment Product Solution and Service
3.7 Date of Enter into Gene Therapies for Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapies for Tumor Treatment Breakdown Data by Type
4.1 Global Gene Therapies for Tumor Treatment Historic Market Size by Type (2018-2024)
4.2 Global Gene Therapies for Tumor Treatment Forecasted Market Size by Type (2024-2029)
5 Gene Therapies for Tumor Treatment Breakdown Data by Application
5.1 Global Gene Therapies for Tumor Treatment Historic Market Size by Application (2018-2024)
5.2 Global Gene Therapies for Tumor Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapies for Tumor Treatment Market Size (2018-2029)
6.2 North America Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Therapies for Tumor Treatment Market Size by Country (2018-2024)
6.4 North America Gene Therapies for Tumor Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapies for Tumor Treatment Market Size (2018-2029)
7.2 Europe Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Therapies for Tumor Treatment Market Size by Country (2018-2024)
7.4 Europe Gene Therapies for Tumor Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapies for Tumor Treatment Market Size (2018-2029)
8.2 Asia-Pacific Gene Therapies for Tumor Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapies for Tumor Treatment Market Size (2018-2029)
9.2 Latin America Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Therapies for Tumor Treatment Market Size by Country (2018-2024)
9.4 Latin America Gene Therapies for Tumor Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapies for Tumor Treatment Market Size (2018-2029)
10.2 Middle East & Africa Gene Therapies for Tumor Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Gene Therapies for Tumor Treatment Introduction
11.1.4 Novartis Revenue in Gene Therapies for Tumor Treatment Business (2018-2024)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Gene Therapies for Tumor Treatment Introduction
11.2.4 Gilead Sciences Revenue in Gene Therapies for Tumor Treatment Business (2018-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Gene Therapies for Tumor Treatment Introduction
11.3.4 Amgen Revenue in Gene Therapies for Tumor Treatment Business (2018-2024)
11.3.5 Amgen Recent Development
11.4 Shanghai Sunway
11.4.1 Shanghai Sunway Company Detail
11.4.2 Shanghai Sunway Business Overview
11.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Introduction
11.4.4 Shanghai Sunway Revenue in Gene Therapies for Tumor Treatment Business (2018-2024)
11.4.5 Shanghai Sunway Recent Development
11.5 Sibiono
11.5.1 Sibiono Company Detail
11.5.2 Sibiono Business Overview
11.5.3 Sibiono Gene Therapies for Tumor Treatment Introduction
11.5.4 Sibiono Revenue in Gene Therapies for Tumor Treatment Business (2018-2024)
11.5.5 Sibiono Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Gene Induced Immunotherapy
Table 3. Key Players of Oncolytic Virotherapy
Table 4. Key Players of Gene Transfer
Table 5. Global Gene Therapies for Tumor Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gene Therapies for Tumor Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Gene Therapies for Tumor Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Gene Therapies for Tumor Treatment Market Share by Region (2018-2024)
Table 9. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Gene Therapies for Tumor Treatment Market Share by Region (2024-2029)
Table 11. Gene Therapies for Tumor Treatment Market Trends
Table 12. Gene Therapies for Tumor Treatment Market Drivers
Table 13. Gene Therapies for Tumor Treatment Market Challenges
Table 14. Gene Therapies for Tumor Treatment Market Restraints
Table 15. Global Gene Therapies for Tumor Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Gene Therapies for Tumor Treatment Market Share by Players (2018-2024)
Table 17. Global Top Gene Therapies for Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Tumor Treatment as of 2022)
Table 18. Ranking of Global Top Gene Therapies for Tumor Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Gene Therapies for Tumor Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gene Therapies for Tumor Treatment Product Solution and Service
Table 22. Date of Enter into Gene Therapies for Tumor Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gene Therapies for Tumor Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2018-2024)
Table 26. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Gene Therapies for Tumor Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2018-2024)
Table 30. Global Gene Therapies for Tumor Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Gene Therapies for Tumor Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Gene Therapies for Tumor Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Gene Therapies for Tumor Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Gene Therapies for Tumor Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Gene Therapies for Tumor Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Gene Therapies for Tumor Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Gene Therapies for Tumor Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Gene Therapies for Tumor Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Gene Therapies for Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Novartis Company Detail
Table 48. Novartis Business Overview
Table 49. Novartis Gene Therapies for Tumor Treatment Product
Table 50. Novartis Revenue in Gene Therapies for Tumor Treatment Business (2018-2024) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. Gilead Sciences Company Detail
Table 53. Gilead Sciences Business Overview
Table 54. Gilead Sciences Gene Therapies for Tumor Treatment Product
Table 55. Gilead Sciences Revenue in Gene Therapies for Tumor Treatment Business (2018-2024) & (US$ Million)
Table 56. Gilead Sciences Recent Development
Table 57. Amgen Company Detail
Table 58. Amgen Business Overview
Table 59. Amgen Gene Therapies for Tumor Treatment Product
Table 60. Amgen Revenue in Gene Therapies for Tumor Treatment Business (2018-2024) & (US$ Million)
Table 61. Amgen Recent Development
Table 62. Shanghai Sunway Company Detail
Table 63. Shanghai Sunway Business Overview
Table 64. Shanghai Sunway Gene Therapies for Tumor Treatment Product
Table 65. Shanghai Sunway Revenue in Gene Therapies for Tumor Treatment Business (2018-2024) & (US$ Million)
Table 66. Shanghai Sunway Recent Development
Table 67. Sibiono Company Detail
Table 68. Sibiono Business Overview
Table 69. Sibiono Gene Therapies for Tumor Treatment Product
Table 70. Sibiono Revenue in Gene Therapies for Tumor Treatment Business (2018-2024) & (US$ Million)
Table 71. Sibiono Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapies for Tumor Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Gene Therapies for Tumor Treatment Market Share by Type: 2022 VS 2029
Figure 3. Gene Induced Immunotherapy Features
Figure 4. Oncolytic Virotherapy Features
Figure 5. Gene Transfer Features
Figure 6. Global Gene Therapies for Tumor Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Gene Therapies for Tumor Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Gene Therapies for Tumor Treatment Report Years Considered
Figure 12. Global Gene Therapies for Tumor Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Gene Therapies for Tumor Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Gene Therapies for Tumor Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Gene Therapies for Tumor Treatment Market Share by Players in 2022
Figure 16. Global Top Gene Therapies for Tumor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Tumor Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapies for Tumor Treatment Revenue in 2022
Figure 18. North America Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Gene Therapies for Tumor Treatment Market Share by Country (2018-2029)
Figure 20. United States Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gene Therapies for Tumor Treatment Market Share by Country (2018-2029)
Figure 24. Germany Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapies for Tumor Treatment Market Share by Region (2018-2029)
Figure 32. China Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Gene Therapies for Tumor Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Gene Therapies for Tumor Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Novartis Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2018-2024)
Figure 47. Gilead Sciences Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2018-2024)
Figure 48. Amgen Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2018-2024)
Figure 49. Shanghai Sunway Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2018-2024)
Figure 50. Sibiono Revenue Growth Rate in Gene Therapies for Tumor Treatment Business (2018-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries